glutamic acid has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreitman, RJ; Pastan, I | 1 |
1 other study(ies) available for glutamic acid and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Importance of the glutamate residue of KDEL in increasing the cytotoxicity of Pseudomonas exotoxin derivatives and for increased binding to the KDEL receptor.
Topics: ADP Ribose Transferases; Amino Acid Sequence; Animals; Bacterial Toxins; Base Sequence; Biological Transport; Carcinoma, Squamous Cell; Cytosol; Endoplasmic Reticulum; Exotoxins; Glutamic Acid; Golgi Apparatus; Humans; Immunotoxins; Leukemia, Lymphocytic, Chronic, B-Cell; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Protein Sorting Signals; Protein Synthesis Inhibitors; Pseudomonas aeruginosa Exotoxin A; Rats; Receptors, Interleukin-2; Receptors, Peptide; Recombinant Fusion Proteins; Tumor Cells, Cultured; Virulence Factors | 1995 |